semaglutide adolescent obesity trial 2022 ObesityWeek 2022: Shows Promise in Adolescents Novo Nordisk (NOVOB) Shot Helps

With integrated metabolic approaches gaining traction, primary care providers, endocrinologists, and diabetes educators will need to revise protocols and adopt longer-term management strategies

A difference in PFS was observed across all subgroups and was independent of previous tyrosine kinase inhibitor treatment and RET pathogenic variant status

A meta-analysis produces a weighted summary result, in which more weight is given to larger studies

Mild nausea, reduced appetite, and occasional digestive changes are common during weeks 14 as your GLP-1 system activates

adult obesity rate declined to 37%, down from a record high of 39.9% in 2022

This medication mimics a natural hormone produced in your gut that signals to the brain that you are full